Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Q3 Productivity Slips To -0.3%, Labor Costs Rise 3.6%

Published 11/05/2019, 10:25 PM
Updated 07/09/2023, 06:31 AM

Wednesday, November 6, 2019

U.S. Productivity in Q3 reported preliminary results (subject to future revisions) ahead of today’s opening bell, with a fairly disappointing outcome: -0.3% on the headline, well beneath the +0.6% expected and the upwardly revised +2.5% for the final print on Q2. This productivity report refers to non-farm goods produced domestically.

To see a negative headline read on U.S. Productivity is thankfully quite rare. The last time we saw this was nearly 4 full years ago, back in December 2015. From the Great Recession a decade ago onward, at 107.513 remains near multi-year highs on the index. From the December 2015 trough, we’ve seen a slow, steady climb from around 102 index points.

Q3 Unit Labor Costs, on the other hand, rose higher than anticipated, up 3.6% from an estimated 2.5% and last quarter’s final +2.6%. So while we see negative output in domestic goods produced over the last 3 months, costs for labor have jumped 100 basis points over the same time period. Here we see some initial signs of economic strain in an otherwise quite robust economy.

CVS Health (NYSE:CVS) posted better-than-expected Q3 earnings this morning, with $1.87 per share beating estimates by 7 cents on revenues of $64.81 billion, which topped expectations by 2.83%. These figures compare favorably to the $1.73 per share and $47.27 billion, respectively, in Q3 2018. Shares are up nearly 3% in the pre-market, higher than CVS’ total year-to-date gains. For more on CVS’ earnings, click here.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Humana (NYSE:HUM) also impressed investors by surpassing estimates on its top and bottom line ahead of today’s open, with $5.08 per share beating by 50 cents on the bottom line and $4.58 billion coming in +0.55% on the top. the health insurance major has not missed on earnings since Q4 2015, and shares are up 2.5% on the earnings release. For more on HUM’s earnings, click here.

Papa John’s (NASDAQ:PZZA) put up a mixed overall Q3 with a miss on the bottom line by 2 cents to 21 cents per share, while $403.71 million in quarterly sales beat the Zacks consensus by 4.13%. Both Q3 figures compare favorably to the year-ago 20 cents per share and $364.01 million reported, respectively. Shares are up another 3.6% in pre-market activity, after already having zoomed up 43.7% year to date. For more on PZZA’s earnings, click here.

Mark Vickery

Senior Editor

Questions or comments about this article and/or its author? Click here>>

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple (NASDAQ:AAPL) sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.

Click here for the 6 trades >>

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Humana Inc. (HUM): Free Stock Analysis Report

CVS Health Corporation (CVS): Free Stock Analysis Report

Papa John's International, Inc. (PZZA): Free Stock Analysis Report

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.